Vimarsana
Biggest News Aggregation in the World

Page 2 - Final Prospectus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Final Prospectus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Final Prospectus Today - Breaking & Trending Today

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting - Vimarsana News

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

SAN DIEGO--(BUSINESS WIRE)--May 1, 2024--

Cemtrex, Inc. Announces Pricing of $10 Million Upsized Underwritten Public Offering - Vimarsana News

Cemtrex, Inc. Announces Pricing of $10 Million Upsized Underwritten Public Offering

Hauppauge, NY, May 01, 2024 --  – Cemtrex, Inc. , an advanced security technology and industrial services company, today announced the pricing of a firm commitment underwritten public offering...

Cemtrex, Inc. Announces Pricing of $10 Million Upsized - Vimarsana News

Cemtrex, Inc. Announces Pricing of $10 Million Upsized

Hauppauge, NY, May 01, 2024 (GLOBE NEWSWIRE) --  – Cemtrex, Inc. (Nasdaq: CETX) (the “Company”), an advanced security technology and industrial services...

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 - Vimarsana News

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024

SALT LAKE CITY, April 29, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 - Vimarsana News

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24

Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15...